Ale Närvänen

3.0k total citations
97 papers, 2.4k citations indexed

About

Ale Närvänen is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Ale Närvänen has authored 97 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 14 papers in Immunology and Allergy and 12 papers in Oncology. Recurrent topics in Ale Närvänen's work include Allergic Rhinitis and Sensitization (10 papers), Food Allergy and Anaphylaxis Research (9 papers) and Peptidase Inhibition and Analysis (9 papers). Ale Närvänen is often cited by papers focused on Allergic Rhinitis and Sensitization (10 papers), Food Allergy and Anaphylaxis Research (9 papers) and Peptidase Inhibition and Analysis (9 papers). Ale Närvänen collaborates with scholars based in Finland, Sweden and United States. Ale Närvänen's co-authors include Antti Vaheri, Tuulia Huhtala, Ulf‐Håkan Stenman, Jussi Rytkönen, Vesa‐Pekka Lehto, Hannu Sariola, Georges Snounou, Päivi Liesi, Hannu Koistinen and Jukka Suni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ale Närvänen

94 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ale Närvänen Finland 30 860 362 290 260 237 97 2.4k
Eric Carlemalm Sweden 23 1.9k 2.2× 216 0.6× 204 0.7× 364 1.4× 147 0.6× 42 3.4k
Christian Roy France 36 2.4k 2.7× 100 0.3× 321 1.1× 526 2.0× 551 2.3× 147 5.0k
Fei Hao China 31 1.3k 1.5× 282 0.8× 184 0.6× 713 2.7× 238 1.0× 191 3.5k
Nicholas E. Sherman United States 41 3.1k 3.6× 228 0.6× 291 1.0× 1.3k 4.8× 143 0.6× 95 6.3k
Mitsuru Nakamura Japan 27 1.4k 1.6× 108 0.3× 85 0.3× 545 2.1× 102 0.4× 175 2.8k
Jean M. Sanger United States 38 3.1k 3.6× 122 0.3× 542 1.9× 458 1.8× 185 0.8× 100 5.8k
Maria Célia Jamur Brazil 25 1.0k 1.2× 189 0.5× 119 0.4× 1.1k 4.4× 330 1.4× 95 2.7k
Ulrike Engel Germany 25 768 0.9× 67 0.2× 196 0.7× 187 0.7× 63 0.3× 68 2.3k
Patrik Maurer Germany 42 2.0k 2.3× 193 0.5× 140 0.5× 760 2.9× 669 2.8× 60 4.7k
Joseph W. Sanger United States 44 4.0k 4.7× 114 0.3× 733 2.5× 131 0.5× 264 1.1× 142 6.7k

Countries citing papers authored by Ale Närvänen

Since Specialization
Citations

This map shows the geographic impact of Ale Närvänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ale Närvänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ale Närvänen more than expected).

Fields of papers citing papers by Ale Närvänen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ale Närvänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ale Närvänen. The network helps show where Ale Närvänen may publish in the future.

Co-authorship network of co-authors of Ale Närvänen

This figure shows the co-authorship network connecting the top 25 collaborators of Ale Närvänen. A scholar is included among the top collaborators of Ale Närvänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ale Närvänen. Ale Närvänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hyvönen, Maija, Juulia Enbäck, Tuulia Huhtala, et al.. (2014). Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors. Molecular Cancer Therapeutics. 13(4). 996–1007. 44 indexed citations
2.
Vlasova, M. A., Jussi Rytkönen, Joakim Riikonen, et al.. (2014). Nanocarriers and the delivered drug: Effect interference due to intravenous administration. European Journal of Pharmaceutical Sciences. 63. 96–102. 6 indexed citations
3.
Huhtala, Tuulia, et al.. (2013). Biodistribution and antitumor effect of Cetuximab-targeted lentivirus. Nuclear Medicine and Biology. 41(1). 77–83. 4 indexed citations
4.
Jääskeläinen, Anne J., et al.. (2012). Surface-activated microtiter-plate microarray for simultaneous CRP quantification and viral antibody detection. Diagnostic Microbiology and Infectious Disease. 75(2). 174–179. 6 indexed citations
5.
Hekim, Can, Janne Weisell, Ale Närvänen, et al.. (2010). Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides. Biological Chemistry. 391(4). 475–9. 8 indexed citations
6.
Kinnunen, Tuure, William W. Kwok, Ale Närvänen, et al.. (2010). Allergen‐specific naïve and memory CD4+ T cells exhibit functional and phenotypic differences between individuals with or without allergy. European Journal of Immunology. 40(9). 2460–2469. 23 indexed citations
7.
Kaikkonen, Minna U., Hanna P. Lesch, Jere T. Pikkarainen, et al.. (2009). (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery. Gene Therapy. 16(7). 894–904. 20 indexed citations
8.
Hakalehto, Elias, et al.. (2007). Aerobic and anaerobic growth modes and expression of type 1 fimbriae in Salmonella. Pathophysiology. 14(1). 61–69. 15 indexed citations
9.
Kinnunen, Tuure, William W. Kwok, Marja Rytkönen‐Nissinen, et al.. (2007). Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy. Journal of Allergy and Clinical Immunology. 119(4). 965–972. 26 indexed citations
10.
Saarelainen, Soili, Tuure Kinnunen, Cécile Buhot, et al.. (2007). Immunotherapeutic potential of the immunodominant T‐cell epitope of lipocalin allergen Bos d 2 and its analogues. Immunology. 123(3). 358–366. 4 indexed citations
11.
Zhu, Lei, Hannu Koistinen, Ping Wu, et al.. (2006). A sensitive proximity ligation assay for active PSA. Biological Chemistry. 387(6). 769–72. 25 indexed citations
12.
Hyvönen, Mervi T., Anne Uimari, Tuomo A. Keinänen, et al.. (2006). Polyamine-regulated unproductive splicing and translation of spermidine/spermine N1-acetyltransferase. RNA. 12(8). 1569–1582. 55 indexed citations
13.
Wu, Ping, Jari Leinonen, Ulf‐Håkan Stenman, et al.. (2004). Conformational and biochemical analysis of the cyclic peptides which modulate serine protease activity. Journal of Peptide Science. 10(7). 439–447. 15 indexed citations
14.
Kinnunen, Tuure, Cécile Buhot, Ale Närvänen, et al.. (2003). The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells. European Journal of Immunology. 33(6). 1717–1726. 22 indexed citations
15.
Turunen, Mikko P., Jonna K. Koponen, Mikko Hiltunen, et al.. (2002). Peptide-Retargeted Adenovirus Encoding a Tissue Inhibitor of Metalloproteinase-1 Decreases Restenosis after Intravascular Gene Transfer. Molecular Therapy. 6(3). 306–312. 37 indexed citations
16.
Närvänen, Ale, et al.. (1997). Detection of Antibodies to Chlamydia trachomatis With Peptide‐Based Species‐SpecificEnzyme Immunoassay. Infectious Diseases in Obstetrics and Gynecology. 5(5). 349–354. 33 indexed citations
17.
Ilonen, Jorma, et al.. (1992). Recognition of Synthetic Peptides with Sequences of Rubella Virus E1 Polypeptide by Antibodies and T Lymphocytes. Viral Immunology. 5(3). 221–228. 8 indexed citations
18.
Närvänen, Ale, et al.. (1988). Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection. Journal of Medical Virology. 26(2). 111–118. 27 indexed citations
19.
20.
Närvänen, Outi, et al.. (1987). A monoclonal antibody against a synthetic peptide reveals common structures among spectrins and α‐actinin. FEBS Letters. 224(1). 156–160. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Carlemalm Breakdown of academic impact, for papers by Christian Roy Breakdown of academic impact, for papers by Fei Hao Breakdown of academic impact, for papers by Nicholas E. Sherman Breakdown of academic impact, for papers by Mitsuru Nakamura Breakdown of academic impact, for papers by Jean M. Sanger Breakdown of academic impact, for papers by Maria Célia Jamur Breakdown of academic impact, for papers by Ulrike Engel Breakdown of academic impact, for papers by Patrik Maurer Breakdown of academic impact, for papers by Joseph W. Sanger
Rankless by CCL
2026